miR-26a promotes neurite outgrowth by repressing PTEN expression

Li,Baoguo; Sun,Hanxiao

doi:10.3892/mmr.2013.1534

miR-26a promotes neurite outgrowth by repressing PTEN expression

Authors:
- Baoguo Li
- Hanxiao Sun
View Affiliations

Affiliations: Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632, P.R. China
Published online on: June 19, 2013 https://doi.org/10.3892/mmr.2013.1534
Pages: 676-680

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A multitude of studies have reported that microRNAs (miRNAs) are important in neuronal development. As a key regulator altering the expression of certain mRNAs, miR-26a has been demonstrated to play a role in the central nervous system (CNS). In the current study, the function of miR-26a in neuronal development was investigated. The overexpression of miR-26a was hypothesized to significantly enhance synaptic plasticity and regulate neuronal morphogenesis. The number and distribution of neurites was markedly increased by miR-26a. In addition, inhibition of miR-26a function attenuated neuronal outgrowth. Furthermore, phosphatase and tensin homolog (PTEN) was identified as a direct target of miR-26a in this process via a luciferase reporter assay. The growth of neurites was consistently suppressed by PTEN overexpression. Therefore, our study demonstrated that miR-26a promoted neurite outgrowth via the suppression of PTEN expression, indicating that miR-26a is important in neuronal development and morphogenesis. miR-26a has the potential to serve as a therapeutic target for patients with Alzheimer's disease (AD).

View Figures

View References

1	Carrillo MC, Brashear HR, Logovinsky V, et al: Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease. Alzheimers Dement. 9:123–131. 2013.
2	McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease. Neurology. 34:9391984.
3	Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
4	Inui M, Martello G and Piccolo S: MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263. 2010. View Article : Google Scholar
5	He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI
6	Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002. View Article : Google Scholar : PubMed/NCBI
7	Deo M, Yu JY, Chung KH, Tippens M and Turner DL: Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn. 235:2538–2548. 2006. View Article : Google Scholar : PubMed/NCBI
8	Vo N, Klein ME, Varlamova O, et al: A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci USA. 102:16426–16431. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
10	Bruno IG, Karam R, Huang L, et al: Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell. 42:500–510. 2011. View Article : Google Scholar : PubMed/NCBI
11	Nikolic M, Chou MM, Lu W, Mayer BJ and Tsai LH: The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature. 395:194–198. 1998. View Article : Google Scholar : PubMed/NCBI
12	Meijering E and Jacob M: Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A. 58:167–176. 2004. View Article : Google Scholar : PubMed/NCBI
13	Zhang YF, Zhang AR, Zhang BC, et al: miR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway. Mol Biol Rep. 40:1711–1720. 2013. View Article : Google Scholar : PubMed/NCBI
14	Miko E, Czimmerer Z, Csánky E, et al: Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res. 35:646–664. 2009. View Article : Google Scholar : PubMed/NCBI
15	Liu B, Wu X, Liu B, et al: miR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta. 1822:1692–1704. 2012. View Article : Google Scholar : PubMed/NCBI
16	Kim H, Huang W, Jiang X, et al: Integrative genome analysis reveals an oncomiR/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad Sci USA. 107:2183–2188. 2010. View Article : Google Scholar : PubMed/NCBI
17	Vaupel JW: Biodemography of human ageing. Nature. 464:536–542. 2010. View Article : Google Scholar : PubMed/NCBI
18	Graves AB, Larson EB, Edland SD, Bowen JD, et al: Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. Am J Epidemiol. 144:760–771. 1996. View Article : Google Scholar : PubMed/NCBI
19	Moceri VM, Kukull WA, Emanuel I, van Belle G and Larson EB: Early-life risk factors and the development of Alzheimer's disease. Neurology. 54:415–420. 2000. View Article : Google Scholar
20	Cheng LC, Pastrana E, Tavazoie M and Doetsch F: miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 12:399–408. 2009. View Article : Google Scholar : PubMed/NCBI
21	Zhao C, Sun G, Li S and Shi Y: A feedback regulatory loop involving microrna-9 and nuclear receptor tlx in neural stem cell fate determination. Nat Struct Mol Biol. 16:365–371. 2009. View Article : Google Scholar : PubMed/NCBI
22	Dunand-Sauthier I, Santiago-Raber ML, Capponi L, et al: Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood. 117:4490–4500. 2011. View Article : Google Scholar : PubMed/NCBI
23	Lobnig BM, Krömeke O, Optenhostert-Porst C and Wolf OT: Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabet Med. 23:32–39. 2006.
24	Zhang B, Liu XX, He JR, et al: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 32:2–9. 2011. View Article : Google Scholar : PubMed/NCBI
25	Alajez NM, Shi W, Hui AB, et al: Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis. 1:e852010. View Article : Google Scholar : PubMed/NCBI
26	Kuhn TB, Meberg PJ, Brown MD, et al: Regulating actin dynamics in neuronal growth cones by ADF/cofilin and rho family GTPases. J Neurobiol. 44:126–144. 2000. View Article : Google Scholar : PubMed/NCBI
27	Jacobson C, Schnapp B and Banker GA: A change in the selective translocation of the Kinesin-1 motor domain marks the initial specification of the axon. Neuron. 49:797–804. 2006. View Article : Google Scholar : PubMed/NCBI
28	Jiang H, Guo W, Liang X and Rao Y: Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell. 120:123–135. 2005.PubMed/NCBI